How Will Cynata’s $1.2M ATM Raise Propel Its Stem Cell Trials?

middle.news 7:02pm on Friday 23rd of January, 2026 AEDT • Biotechnology Read Story

How Will Cynata’s $1.2M ATM Raise Propel Its Stem Cell Trials?

7:02pm on Friday 23rd of January, 2026 AEDT Key Points Raised $1.2 million net through At-The-Market equity raise Issued 4.3 million shares at $0.28 each, an 11.1% discount Funds allocated to working capital for clinical-stage operations Shares issued to Acuity Capital under existing ATM agreement Read Story

middle. Tap to Read Tap the card to read the full analysis about Cynata Therapeutics (ASX:CYP) OPEN ARTICLE